Reference and point-of-care testing for G6PD deficiency: Blood disorder interference, contrived specimens, and fingerstick equivalence and precision.

Certain clinical indications and treatments such as the use of rasburicase in cancer therapy and 8-aminoquinolines for Plasmodium vivax malaria treatment would benefit from a point-of-care test for glucose-6-phosphate dehydrogenase (G6PD) deficiency. Three studies were conducted to evaluate the perf...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Sampa Pal, Jane Myburgh, Pooja Bansil, Amanda Hann, Lynn Robertson, Emily Gerth-Guyette, Gwen Ambler, Greg Bizilj, Maria Kahn, Stephanie Zobrist, Michelle R Manis, Nickolas A Styke, Vajra Allan, Richard Ansbro, Tobi Akingbade, Andrew Bryan, Sean C Murphy, James G Kublin, Mark Layton, Gonzalo J Domingo
Format:	article
Langue:	EN
Publié:	Public Library of Science (PLoS) 2021
Sujets:	Medicine R Science Q
Accès en ligne:	https://doaj.org/article/af90750e5f424c59a8c771e3f4e6f118
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Soyez le premier à ajouter un commentaire!

Reference and point-of-care testing for G6PD deficiency: Blood disorder interference, contrived specimens, and fingerstick equivalence and precision.

Documents similaires